Canada Life’s Minerva Neurosciences NERV Stock Holding History

Canada Life’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-338	Closed	-$15K	–	1852
2019 Q2	$15K	Hold	338	–	–	﹤0.01%	2607
2019 Q1	$21K	Hold	338	–	–	﹤0.01%	2369
2018 Q4	$18K	Hold	338	–	–	﹤0.01%	2548
2018 Q3	$34K	Hold	338	–	–	﹤0.01%	2454
2018 Q2	$22K	Hold	338	–	–	﹤0.01%	2512
2018 Q1	$17K	Hold	338	–	–	﹤0.01%	2513
2017 Q4	$16K	Hold	338	–	–	﹤0.01%	2512
2017 Q3	$20K	Hold	338	–	–	﹤0.01%	2491
2017 Q2	$24K	Hold	338	–	–	﹤0.01%	2474
2017 Q1	$22K	Hold	338	–	–	﹤0.01%	2447
2016 Q4	$32K	Buy	+338	New	+$34.5K	﹤0.01%	2420

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Canada Life's NERV Position: Q3 2019 in Review

Canada Life sold out of Minerva Neurosciences (NERV) in Q3 2019, closing a stake of 338 shares — an estimated $15K sold.

Canada Life first reported a position in NERV in Q4 2016 and held it in 11 quarters. The position peaked at $34K in Q3 2018. 87 funds tracked by Wall St. Rank hold NERV as of Q3 2019.

Canada Life reported no remaining Minerva Neurosciences position as of Q3 2019 after selling out during the quarter.
Canada Life sold 338 Minerva Neurosciences shares in Q3 2019, an estimated $15K.
Canada Life first reported a position in Minerva Neurosciences in Q4 2016 and held it in 11 quarters.
Canada Life's Minerva Neurosciences position peaked at $34K in Q3 2018.
87 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2019.

Based on Canada Life's 13F filing for Q3 2019, filed 25 Oct 2019.